Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Metastatic colorectal cancer (CRC) with a mismatch repair-deficiency (MMR-
D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as …
D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as …
The immune contexture in human tumours: impact on clinical outcome
Tumours grow within an intricate network of epithelial cells, vascular and lymphatic vessels,
cytokines and chemokines, and infiltrating immune cells. Different types of infiltrating …
cytokines and chemokines, and infiltrating immune cells. Different types of infiltrating …
Immune infiltration in human tumors: a prognostic factor that should not be ignored
J Galon, MC Dieu-Nosjean, E Tartour… - Oncogene, 2010 - nature.com
The natural history of a tumor includes phases of 'in situ'growth, invasion, extravasation and
metastasis. During these phases, tumor cells interact with their microenvironment and are …
metastasis. During these phases, tumor cells interact with their microenvironment and are …
The immune biology of microsatellite-unstable cancer
Deficient DNA mismatch repair (MMR) boosts the accumulation of frameshift mutations in
genes encompassing coding microsatellites (cMS). This results in the translation of proteins …
genes encompassing coding microsatellites (cMS). This results in the translation of proteins …
Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
K Nosho, Y Baba, N Tanaka, K Shima… - The Journal of …, 2010 - Wiley Online Library
The abundance of tumour‐infiltrating T‐cells has been associated with microsatellite
instability (MSI) and a favourable prognosis in colorectal cancer. However, numerous …
instability (MSI) and a favourable prognosis in colorectal cancer. However, numerous …
Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal cancer
D Waniczek, Z Lorenc, M Śnietura, M Wesecki… - Archivum immunologiae …, 2017 - Springer
The aim of the study is the assessment of the intensity of the infiltration of tumor-associated
macrophages (TAMs) CD68+/iNOS− and Tregs CD8+/FoxP3+ in colorectal cancer (CRC) …
macrophages (TAMs) CD68+/iNOS− and Tregs CD8+/FoxP3+ in colorectal cancer (CRC) …
High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients
DM Frey, RA Droeser, CT Viehl, I Zlobec… - … journal of cancer, 2010 - Wiley Online Library
Regulatory T cells (Treg) inhibit the generation of host‐versus‐tumor immunity via
suppression of tumor‐specific effector T‐cell responses and development of immune …
suppression of tumor‐specific effector T‐cell responses and development of immune …
Cancer immunology—analysis of host and tumor factors for personalized medicine
S Ogino, J Galon, CS Fuchs, G Dranoff - Nature reviews Clinical …, 2011 - nature.com
Immune cells in the tumor microenvironment have an important role in regulating tumor
progression. Therefore, stimulating immune reactions to tumors can be an attractive …
progression. Therefore, stimulating immune reactions to tumors can be an attractive …
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
A Kirilovsky, F Marliot, C El Sissy… - International …, 2016 - academic.oup.com
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) tumor, nodes, metastasis (TNM) classification system based on tumor features …
(AJCC/UICC) tumor, nodes, metastasis (TNM) classification system based on tumor features …
Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo
E Freund, KR Liedtke, J van der Linde… - Scientific reports, 2019 - nature.com
Metastatic colorectal cancer is the fourth most common cause of cancer death. Current
options in palliation such as hyperthermic intraperitoneal chemotherapy (HIPEC) present …
options in palliation such as hyperthermic intraperitoneal chemotherapy (HIPEC) present …